P. Diana Chiu active positions
| Companies | Position | Start | End |
|---|---|---|---|
Seahorse Bioscience, Inc.
 Seahorse Bioscience, Inc. Medical SpecialtiesHealth Technology Seahorse Bioscience, Inc. provides metabolic analyzers and stress kits. Its medical device is use to determine a new therapeutic approach in treating acute myeloid leukemia. The company was founded on November 2, 2000 and is headquartered in Billerica, MA. | Director/Board Member | - | - |
| Corporate Secretary | - | - | |
ACEA Biosciences, Inc.
 ACEA Biosciences, Inc. BiotechnologyHealth Technology ACEA Biosciences, Inc. develops bio-sensor platform based on microelectronic technologies. The firm pioneers in development and commercialization of innovative cell analysis instrumentation for life sciences, and is also engaged in drug discovery and pharmaceutical development. Its xCELLigence impedance-based, label-free, real-time cell analysis systems and NovoCyte benchtop flow cytometers are used in preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, and basic academic research. The company was founded in 2002 and is headquartered in San Diego, CA. | Director/Board Member | - | - |
Career history of P. Diana Chiu
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 2 |
| Corporate Secretary | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Seahorse Bioscience, Inc.
Seahorse Bioscience, Inc. Medical SpecialtiesHealth Technology Seahorse Bioscience, Inc. provides metabolic analyzers and stress kits. Its medical device is use to determine a new therapeutic approach in treating acute myeloid leukemia. The company was founded on November 2, 2000 and is headquartered in Billerica, MA. | Health Technology |
ACEA Biosciences, Inc.
ACEA Biosciences, Inc. BiotechnologyHealth Technology ACEA Biosciences, Inc. develops bio-sensor platform based on microelectronic technologies. The firm pioneers in development and commercialization of innovative cell analysis instrumentation for life sciences, and is also engaged in drug discovery and pharmaceutical development. Its xCELLigence impedance-based, label-free, real-time cell analysis systems and NovoCyte benchtop flow cytometers are used in preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, and basic academic research. The company was founded in 2002 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- P. Diana Chiu
- Experience
